Entrepreneurial Roundtable

March 21,6:30 PM - 8:45 PM

Practical BioTech -- Finding an Entrepreneurial Opportunity in the Treatment and Prevention of Kidney Stones

Hear how a non-physican transformed basic medical research into a business providing a unique service to doctors across the country. Read more.

Where:
Illinois Institute of Technology -- Wheaton, IL Campus
First Floor
East Loop Road
Wheaton, IL

Cost:
$4.00 for pizza and soda

Program:
6:30 -7:15 p.m: Networking & Pizza
7:15 - 8:45 p.m.: Program

Registration:
Mary Brown
marybrown@businesslegalexperts.com
630-527-8552, ext. 303

Please register by 4:00 p.m. on date of event

This event will fill up quickly.

Questions:
Bill Wentz, '88
630-527-8552
billwentz@businesslegalexperts.com

Event Details:
Recurring kidney stones affect some 5% of the population. They are not only very painful but can lead to recurrent hospital visits and surgery. Using research developed by his father, a professor at the University of Chicago Medical School, Brian Coe has built a company, LithoLink Corporation, that uses testing and disease management techniques that have been shown to reduce kidney stone risk by up to 80%. LithoLink performs the specialized tests needed to determine the cause of a patient's kidney stones. LithoLink also provides services to support physicians in managing the patient's condition in order to reduce or eliminate the recurrence of kidney stones. LithoLink delivers its services through a combination of physician education, laboratory testing and interpretive software. Physicians across the country are using LithoLink including doctors in such leading medical institutions as Harvard, New York University and the University of California at San Francisco. Brian Coe was one of the featured speakers at January's seminar on BioTech Start-Up's that was co-sponsored by the GSB Entrepreneurial Roundtable. Come to hear how a non-physician with an entrepreneurial drive can take basic medical research and transform it into a profitable, growing business that is used by more and more physicians across the country. This is the practical approach to biotech.